number of susceptible animals, including wild animals where applicable;

estimated number of clinically or subclinically infected or infested animals including wild animals, where applicable;

estimated number of animals that have died or, in the case of wild animals, that have been found dead;

number of animals killed;

number of animals slaughtered;

number of susceptible colonies;

number of clinically or subclinically infected or infested colonies;

number of dead colonies;

number of destroyed colonies;

estimated number or biomass of susceptible animals, including wild animals where applicable;

estimated number or biomass of clinically or subclinically infected animals, including wild animals where applicable;

estimated number or biomass of animals that have died or in the case of wild animals, that have been found dead;

estimated number or biomass of animals killed;

estimated number or biomass of animals slaughtered.

number of establishments keeping animals of the targeted animal population excluding establishments falling under the derogation in accordance with Article 19 of Commission Delegated Regulation (EU) 2020/689 ( 1 ) at 31 December;

number of animals of the targeted animal population kept in the establishments referred to in point (a) at 31 December;

number of establishments with disease-free status including establishments with suspended disease-free status, with vaccination or without vaccination, where relevant, out of the number of establishments referred to in point (a) at 31 December;

number of animals kept in the establishments referred to in point (c);

number of establishments confirmed infected during the reporting period.

Number of indicator animals tested per species;

Number of confirmed cases by species.

Number and dates of vaccination campaigns;

Vaccine bait density achieved and, if the total size of the vaccination area per vaccination campaign is greater than 20 000  km2, vaccine bait density maps;

Upon request of the Commission, electronic files containing:

Information on the monitoring of the effectiveness of the vaccination, with maps with data of:

number of animals positive to the biomarker test/number of biomarker tests performed;

number of animals positive to serological tests/number of serological tests performed.

number of establishments keeping animals of the targeted animal population at 31 December;

number of animals of the targeted animal population kept in the establishments referred to in point (a) at 31 December;

number of establishments keeping animals of the targeted animal population where vaccination against infection with BTV has been carried out and number of animals vaccinated during the reporting period, by species and, if relevant, by serotypes of BTV;

number of outbreaks by BTV serotype confirmed during the reporting period;

number and location of vector protected establishments, where relevant;

description of seasonally BTV-free areas and dates of beginning and end of the vector-free period, where relevant.

number of approved aquaculture establishments and number of registered aquaculture establishments keeping animals of the targeted animal population and, where relevant, sampling points in wild populations, which are included in the eradication programme at 31 December;

number of aquaculture establishments and, where relevant, sampling points in wild populations, out of the number of establishments or sampling points referred to in point (a), which are not infected at 31 December;

number of infected aquaculture establishments and, where relevant, sampling points in wild populations with confirmed case(s) out of the number of establishments and sampling points referred to in point (a) at 31 December;

number of new infected aquaculture establishments and, where relevant, sampling points in wild populations, with confirmed case(s) out of the number of establishments and sampling points referred to in point (a) at 31 December.

the results of a survey conducted for at least one year in all establishments or groups of establishments keeping listed species within the Member State, zone or compartment, and where required, sampling points in wild populations. They must have been tested using a sample size that allows detection of infection with Bonamia exitiosa with a 95 % level of confidence, if the disease agent is present in the population at a prevalence rate of 2 %;

measures applied to prevent the introduction of Bonamia exitiosa into the territory concerned;

disease control measures applied in the event of an outbreak;

the results of a survey conducted for at least one year in all establishments or groups of establishments keeping listed species within the Member State, zone or compartment, and where required, sampling points in wild populations. They must have been tested using a sample size that allows detection of infection with WSSV with a 95 % level of confidence, if the disease agent is present in the population at a prevalence rate of 2 %;

measures applied to prevent the introduction of WSSV into the territory concerned;

disease control measures applied in the event of an outbreak.

number of establishments keeping bovine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 at 31 December of each year for the last three years;

number of bovine animals kept in the establishments referred to in point (a) at 31 December of each year for the last three years;

number of establishments keeping bovine animals with the status free from infection with Brucella abortus, B. melitensis and B. suis without vaccination including establishments with suspended disease-free status at 31 December of each year for the last three years;

number of bovine animals kept in the establishments referred to in point (c) at 31 December of each year for the last three years;

number of establishments keeping bovine animals tested with a serological test for infection with Brucella abortus, B. melitensis and B. suis each year for the last three years;

number of establishments with suspicion following the testing referred to in point (e) each year for the last three years;

number of abortion cases from kept bovine animals that may have been caused by infection with Brucella abortus, B. melitensis and B. suis investigated each year for the last three years;

date of last confirmed case of infection with Brucella abortus, B. melitensis and B. suis in kept bovine animals;

date of last vaccination against infection with Brucella abortus, B. melitensis and B. suis of kept bovine animals;

number of establishments keeping ovine or caprine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 at 31 December of each year for the last three years;

number of ovine and caprine animals kept in the establishments referred to in point (a) at 31 December of each year for the last three years;

number of establishments keeping ovine or caprine animals with the status free from infection with Brucella abortus, B. melitensis and B. suis without vaccination including establishments with suspended disease-free status at 31 December of each year for the last three years;

number of ovine and caprine animals kept in the establishments referred to in point (c) at 31 December of each year for the last three years;

number of establishments keeping ovine or caprine animals tested for infection with Brucella abortus, B. melitensis and B. suis each year for the last three years;

number of establishments with suspicion following the testing referred to in point (e) each year for the last three years;

number of abortion cases from ovine or caprine animals that may have been caused by infection with Brucella abortus, B. melitensis and B. suis investigated each year for the last three years;

date of last confirmed case of infection with Brucella abortus, B. melitensis and B. suis in kept ovine or caprine animals;

date of last vaccination against infection with Brucella abortus, B. melitensis and B. suis of kept ovine or caprine animals;

number of establishments keeping bovine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 at 31 December of each year for the last three years;

number of bovine animals kept in the establishments referred to in point (a) at 31 December of each year for the last three years;

number of establishments keeping bovine animals with the status free from infection with MTBC including establishments with suspended disease-free status at 31 December of each year for the last three years;

number of bovine animals kept in the establishments referred to in point (c) at 31 December of each year for the last three years;

number of establishments keeping bovine animals tested for MTBC each year for the last three years;

number of establishments with suspicion following the testing referred to in point (e) each year for the last three years;

number of bovine animals slaughtered, presenting suspected lesions of infection with MTBC that have been investigated each year the last three years;

number of establishments confirmed infected with MTBC each year the last three years;

number of establishments keeping bovine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 at 31 December of each year for the last three years;

number of bovine animals kept in the establishments referred to in point (a) at 31 December of each year for the last three years;

number of establishments keeping bovine animals with the status free from EBL including establishments with suspended disease-free status at 31 December of each year for the last three years;

number of bovine animals kept in the establishments referred to in point (c) at 31 December of each year for the last three years;

number of establishments keeping bovine animals tested for EBL each year for the last three years;

number of establishments with suspicion following the testing referred to in point (e) each year for the last three years;

number of samples from slaughtered bovine animals over 24 months of age with tumors that could be caused by EBL being subjected to laboratory examination to confirm or rule out the presence of EBL each year for the last three years;

number of establishments confirmed infected with EBL each year for the last three years;

number of establishments keeping bovine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 at 31 December of each year for the last three years;

number of bovine animals kept in the establishments referred to in point (a) at 31 December of each year for the last three years;

number of establishments with the status free from IBR/IPV including establishments with suspended disease-free status at 31 December of each year for the last three years;

number of bovine animals kept in the establishments referred to in point (c) at 31 December of each year for the last three years;

number of establishments tested for IBR/IPV each year for the last three years;

number of establishments with suspicion following the testing referred to in point (e) each year for the last three years;

number of establishments confirmed infected with IBR/IPV each year for the last three years;

date of prohibition of vaccination against IBR/IPV of kept bovine animals;

number of establishments keeping porcine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 at 31 December of each year for the last three years;

number of porcine animals kept in the establishments referred to in point (a) at 31 December of each year for the last three years;

number of establishments with the status free from infection with ADV including establishments with suspended disease-free status at 31 December of each year for the last three years;

number of porcine animals kept in the establishments referred to in point (c) at 31 December of each year for the last three years;

number of establishments where surveillance has been carried out to discover any clinical, virological or serological evidence of infection with ADV each year for the last three years;

number of porcine animals tested in the establishments referred to in point (e) each year for the last three years;

number of establishments confirmed infected with ADV each year for the last three years;

date of prohibition of vaccination against ADV of kept porcine animals;

number of establishments keeping bovine animals, excluding establishments falling under the derogation in accordance with Article 19 of Delegated Regulation (EU) 2020/689 at 31 December of each year for the last three years;

number of bovine animals kept in the establishments referred to in point (a) at 31 December of each year for the last three years;

number of establishments with the status free from BVD including establishments with suspended disease-free status at 31 December of each year for the last three years;

number of bovine animals kept in the establishments referred to in point (c) at 31 December of each year for the last three years;

number of establishments tested for BVD each year for the last three years;

number of establishments with suspicion following the testing referred to in point (e) each year for the last three years;

number of establishments confirmed infected with BVD each year for the last three years;

date of prohibition of vaccination against BVD of kept bovine animals;

surveillance, including at least maps with data of:

vaccination of wild animals:

number of confirmed cases for which infection with RABV did not occur in the territory concerned (imported cases);

if epidemiological links in cases referred to in point (c) have been identified, the results of increased surveillance carried out over a period of 6 months following the death of the animal concerned, where relevant;

territorial scope with a map and a description and demarcation of the geographical and administrative areas covered by the eradication programme and the names of the zones and regions, if more than one region is included in the territorial scope of the programme; where relevant, the reasons for applying the derogation provided for in Article 37(3) of Delegated Regulation (EU) 2020/689 and evolution of the zone during the programme;

the number of establishments keeping animals of the targeted animal population on 31 December;

the number of animals of the targeted animal population kept in the establishments referred to in point (b) on 31 December;

sampling schemes implemented annually: mapping unit and selection criteria implemented, frequency of testing, number of tests, type of diagnostic methods and results;

number of confirmed cases by zone, species, year/months and BTV serotype(s);

number of animals vaccinated by year, species and BTV serotype(s);

derogations for movements granted, number of animals concerned and, where relevant, adaptation of the surveillance implemented;

coordinated measures with other Member States or third countries, where relevant, and adaptation of the surveillance to external sources of infection with BTV;

number of approved aquaculture establishments, and where relevant, the number of registered aquaculture establishments keeping animals of the targeted animal population and sampling points in wild populations, which are included in the eradication programme, as well as maps showing the location of establishments and sampling points in wild populations;

number of aquaculture establishments and, where relevant, sampling points in wild populations, out of the number of establishments and sampling points referred to in point (a), which are not infected;

number of animal health visits per approved and where relevant, registered aquaculture establishments;

number of samplings per approved and where relevant, registered aquaculture establishments and sampling points in wild populations, as well as details of species, results of sampling (positive or negative) and water temperatures at the time of sampling;

number of infected aquaculture establishments and, where relevant, sampling points in wild populations with confirmed cases(s) out of the number of establishments referred to in point (a);

number of new infected aquaculture establishments and, where relevant, sampling points in wild populations with confirmed case(s) out of the number of establishments referred to in point (a).

the number of establishments keeping animals of the targeted animal population by health status ( 3 ) excluding establishments falling under the derogation referred to in point (6)(f) at 31 December;

the number of animals of the targeted animal population kept in the establishments referred to in point (a) by health status;

maps indicating the density of the targeted animal population referred to in point (b) by health status;

timeline with prevalence, incidence data and, where relevant, vaccination history covering at least the past 5 years; and

information as regards the epidemiological situation in additional animal populations, where relevant.

the sampling schemes and diagnostic methods to be used in accordance with Annex IV to Delegated Regulation (EU) 2020/689:

the disease control measures to be applied in the event of a confirmed case;

the biosecurity and risk mitigating measures to be implemented;

type of vaccine(s) to be used and the vaccination scheme, if relevant;

the measures to be implemented as regards additional animal populations, if relevant;

the derogations to be applied in accordance with Article 19 of Delegated Regulation (EU) 2020/689, if relevant;

coordinated measures with other Member States or third countries, if relevant.

the authorities in charge of coordinating and supervising the implementation of the programme;

responsibilities of all stakeholders involved.

the expected annual decrease of the number of infected establishments;

the expected annual increase of the number of disease-free establishments.

number of confirmed cases by listed animal species;

maps indicating the distribution of confirmed cases referred to in point (a) per year;

disease control strategy and results of control measures.

surveillance, including at least:

if relevant, vaccination, including at least:

the disease control measures to be applied in the event of a confirmed case;

the public information campaigns to be implemented;

the measures to be implemented to reduce the contact with infected animals;

the coordinated measures with other Member States or third countries, where relevant.

the authorities in charge of coordinating and supervising the implementation of the programme;

responsibilities of all stakeholders involved.

the expected annual decrease of the number of outbreaks;

the expected number of confirmed outbreaks in areas with outbreaks during the previous year;

the expected percentage of sero-conversion in targeted animal populations;

the expected percentage of vaccine uptake in animals of the targeted species.

the number of establishments keeping animals of the targeted animal population at 31 December;

the number of animals of the targeted animal population kept in the establishments referred to in point (a);

maps indicating:

timeline with prevalence, incidence data and, where relevant, vaccination history covering at least the past 5 years;

results of vector surveillance covering at least the past 5 years;

information as regards the epidemiological situation in additional animal populations, where relevant.

details of the active surveillance to be implemented in accordance with Section 4 of Chapter 1 of Part II of Annex V to Delegated Regulation (EU) 2020/689 with:

type of vaccine(s) to be used and vaccination schemes for vaccination of the relevant targeted animal population, where relevant;

procedure and diagnostic methods to confirm or rule out the disease in the event of a suspected case;

the disease control measures to be applied in the event of a confirmed case;

movement restrictions implemented for movements of kept animals and germinal products;

the biosecurity and risk mitigating measures to be implemented;

details on vector surveillance and, where relevant, the establishment of seasonally BTV-free areas;

details on the granting to establishments of the status ‘vector protected establishment’, where relevant;

coordinated measures with other Member States or third countries, where relevant.

the authorities in charge of coordinating and supervising the implementation of the programme;

responsibilities of all stakeholders involved.

the expected annual decrease of the number of confirmed cases in the targeted animal population;

the expected annual increase of the number of disease-free geographical units;

the expected vaccination coverage, where relevant.

the number of approved aquaculture establishments and the number of registered aquaculture establishments keeping animals of the targeted animal population, by type of production and by health status;

listed species kept in the aquaculture establishments referred to in point (a) by health status;

maps indicating:

information as regards the epidemiological situation in wild aquatic animals, where relevant.

the sampling schemes and diagnostic methods to be used in accordance with Annex VI to Delegated Regulation (EU) 2020/689 for:

the disease control measures to be applied in the event of a confirmed case;

the biosecurity and risk mitigating measures to be implemented;

vaccination schemes, where relevant;

the measures to be implemented as regards wild aquatic animals and the number and geographical location of sampling points where relevant;

the derogations to be applied in accordance with Article 47(4), Article 51(2) or Article 53 of Delegated Regulation (EU) 2020/689, where relevant;

coordinated measures with other Member States or third countries, where relevant.

the authorities in charge of coordinating and supervising the implementation of the programme;

responsibilities of all stakeholders involved.

the expected annual decrease of the number of infected aquaculture establishments and where relevant, sampling points in wild populations;

the expected annual increase of the number of aquaculture establishments and, where relevant, sampling points in wild populations that tested negative;

the expected vaccination coverage, where relevant.